This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Should You Invest in the Invesco Water Resources ETF (PHO)?
by Zacks Equity Research
Sector ETF report for PHO
Is Trending Stock Danaher Corporation (DHR) a Buy Now?
by Zacks Equity Research
Danaher (DHR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why Is Danaher (DHR) Up 6.6% Since Last Earnings Report?
by Zacks Equity Research
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why the Market Dipped But Danaher (DHR) Gained Today
by Zacks Equity Research
Danaher (DHR) reachead $255.71 at the closing of the latest trading day, reflecting a +0.33% change compared to its last close.
The Zacks Analyst Blog Highlights Alphabet, Bank of America, Advanced Micro Devices, Danaher and TJX
by Zacks Equity Research
Alphabet, Bank of America, Advanced Micro Devices, Danaher and TJX are included in this Analyst Blog.
ITT Q4 Earnings In Line With Estimates, Revenues Increase Y/Y
by Zacks Equity Research
ITT's Q4 revenues increase 7% year over year, driven by higher Friction original equipment volumes in the Motion Technologies segment and pricing actions in the Connect & Control Technologies segment.
Carlisle (CSL) Q4 Earnings Beat Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Carlisle (CSL) fourth-quarter 2023 results benefit from higher revenues across the Carlisle Construction Materials segment.
The Zacks Analyst Blog Highlights Eli Lilly, Danaher, Citigroup, Shopify and Canadian Pacific Kansas
by Zacks Equity Research
Eli Lilly, Danaher, Citigroup, Shopify and Canadian Pacific Kansas are included in this Analyst Blog.
Top Stock Reports for Eli Lilly, Danaher & Citigroup
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).
Markel's (MKL) Q4 Earnings Beat, Revenues Lag Estimates
by Zacks Equity Research
Markel's (MKL) fourth-quarter results reflect improved earned premiums and increased net investment income.
Danaher (DHR) Q4 Earnings Beat, Biotechnology Sales Dip Y/Y
by Zacks Equity Research
While Danaher (DHR) surpasses Q4 earnings and revenue estimates, its performance is hurt by a decrease in the sale of COVID-related products and weak demand in the Biotechnology segment.
Danaher (DHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Danaher (DHR) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 10% and 6.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Griffon (GFF) to Report Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
Griffon's (GFF) Q1 results are likely to gain from strength in the HBP segment. However, weakness in the CPP segment, along with higher marketing costs, is expected to have hurt its performance.
Honeywell (HON) Gears Up to Post Q4 Earnings: What to Expect?
by Zacks Equity Research
Honeywell's (HON) fourth-quarter results are likely to have benefited from strength across its businesses. Weakness in the warehouse automation market and high costs and expenses might have been spoilsports.
Why Danaher (DHR) Might Surprise This Earnings Season
by Zacks Equity Research
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Danaher (DHR) Gears Up to Post Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Danaher's (DHR) Q4 earnings are likely to have been hurt by weakness in the Biotechnology and Diagnostics units owing to lower sales of COVID-related products. Improving supply chains and strong price realization are expected to have been positives.
Seeking Clues to Danaher (DHR) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Danaher (DHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Is Invesco Global Water ETF (PIO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PIO
Danaher (DHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) reachead $231.97 at the closing of the latest trading day, reflecting a +0.4% change compared to its last close.
Can General Electric (GE) Q4 Earnings Beat on Aerospace Boost?
by Zacks Equity Research
Strength in the Aerospace segment and accretive acquisitions are likely to aid General Electric's (GE) fourth-quarter 2023 results.
3M (MMM) Gears Up to Post Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
3M's (MMM) fourth-quarter 2023 results are likely to have gained from strength across its automotive OEM and medical solutions businesses. However, weak commercial solutions and transportation safety markets might have hurt its results.
Why Danaher (DHR) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher (DHR) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Danaher (DHR) reachead $226.75 at the closing of the latest trading day, reflecting a +0.67% change compared to its last close.